Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/29784
Title: Hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome in a 26-year-old woman with cystic fibrosis: A case report.
Authors: Dabscheck E.;Reid D.;Geake J.
Institution: (Geake) Department of Respiratory and Sleep Medicine, Monash Medical Centre, 246 Clayton Road, Clayton 3168, Australia (Geake, Dabscheck) Department of Respiratory Medicine, Hobart, TAS 7001, Australia (Dabscheck) Department of Allergy, Immunology and Respiratory Medicine, Alfred Hospital, Commercial Road, Prahan, Melbourne 3181, Australia (Reid) Adult Cystic Fibrosis Centre, Prince Charles Hospital, Rode Road, Chermside, QLD 4032, Australia (Reid) Tasmanian Adult Cystic Fibrosis Unit, Hobart, TAS 7001, Australia
Issue Date: 5-Dec-2012
Copyright year: 2012
Publisher: BioMed Central Ltd. (Floor 6, 236 Gray's Inn Road, London WC1X 8HB, United Kingdom)
Place of publication: United Kingdom
Publication information: Journal of Medical Case Reports. 6 (no pagination), 2012. Article Number: 134. Date of Publication: 2012.
Abstract: Introduction: The microangiopathic hemolysis, elevated liver enzymes, and low platelet (HELLP) syndrome is a rare and potentially fatal complication of pregnancy. Here, to the best of our knowledge, we describe only the second reported case of this syndrome in a woman with cystic fibrosis. Case presentation: This report describes the case of a 26-year-old woman of Caucasian ethnicity with mild cystic fibrosis bronchiectasis who ultimately manifested the triad of microangiopathic hemolysis, elevated liver enzymes, and low platelet count in the third trimester of pregnancy. Her baby was delivered successfully after a semi-elective caesarean section. Conclusion(s): Pregnancies in patients with cystic fibrosis are associated with an increased rate of complications. This case is of importance as it describes only for the second time the successful delivery of a baby in a women with cystic fibrosis, in a pregnancy also threatened by the microangiopathic hemolysis, elevated liver enzymes, and low platelet syndrome. This case will be of special interest to obstetricians, pediatricians, and medical, nursing and allied health staff involved in the delivery of cystic fibrosis care. © 2012 Geake et al.; licensee BioMed Central Ltd.
DOI: http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1186/1752-1947-6-134
ISSN: 1752-1947 (electronic)
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/29784
Type: Article
Subjects: case report
Caucasian
cesarean section
corticosteroid therapy
creatinine urine level
*cystic fibrosis
diabetes mellitus/dt [Drug Therapy]
disease exacerbation
elective surgery
female
fetus lung maturation
follow up
forced expiratory volume
gestational age
glycemic control
*HELLP syndrome/dt [Drug Therapy]
HELLP syndrome/dt [Drug Therapy]
hemoglobin blood level
high risk pregnancy
human
insulin treatment
lactate dehydrogenase blood level
lung disease
lung function
membrane rupture
nausea/si [Side Effect]
outpatient care
pancreas insufficiency
preeclampsia
priority journal
protein urine level
Pseudomonas infection
spinal anesthesia
systolic blood pressure
third trimester pregnancy
aztreonam/dt [Drug Therapy]
aztreonam/iv [Intravenous Drug Administration]
betamethasone/cb [Drug Combination]
betamethasone/dt [Drug Therapy]
betamethasone/im [Intramuscular Drug Administration]
ciprofloxacin/ae [Adverse Drug Reaction]
ciprofloxacin/po [Oral Drug Administration]
creatinine/ec [Endogenous Compound]
hemoglobin/ec [Endogenous Compound]
hemoglobin A1c/ec [Endogenous Compound]
insulin/dt [Drug Therapy]
lactate dehydrogenase/ec [Endogenous Compound]
metoclopramide/po [Oral Drug Administration]
drug tolerability
thrombocyte count
treatment duration
unplanned pregnancy
urinalysis
vaginal delivery
alanine aminotransferase/ec [Endogenous Compound]
albumin/ec [Endogenous Compound]
aztreonam/cb [Drug Combination]
adult
alanine aminotransferase blood level
Apgar score
article
blood pressure
body mass
bronchiectasis
diabetes mellitus / drug therapy
disease exacerbation
drug tolerability
elective surgery
female
fetus lung maturation
follow up
forced expiratory volume
gestational age
glycemic control
*HELLP syndrome / *drug therapy
HELLP syndrome / drug therapy
hemoglobin blood level
high risk pregnancy
human
insulin treatment
lactate dehydrogenase blood level
lung disease
lung function
membrane rupture
nausea / side effect
outpatient care
pancreas insufficiency
preeclampsia
priority journal
protein urine level
Pseudomonas infection
spinal anesthesia
systolic blood pressure
body mass
thrombocyte count
treatment duration
unplanned pregnancy
urinalysis
vaginal delivery
blood pressure
article
Apgar score
alanine aminotransferase blood level
adult
third trimester pregnancy
bronchiectasis
case report
Caucasian
cesarean section
corticosteroid therapy
creatinine urine level
*cystic fibrosis
Type of Clinical Study or Trial: Case series or case report
Appears in Collections:Articles

Show full item record

Page view(s)

2
checked on Aug 16, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.